Pfizer Inc. et al. v. Teva Pharmaceuticals USA, Inc.

1:18-cv-01940 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Leonard P. Stark
Filed Dec. 7, 2018
Terminated Sept. 8, 2021
Case Flags CLOSED, MEDIATION-CJB, and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
Last Updated: 1 year, 1 month ago Show Interactive Timeline
Upcoming Events
8 Months
  • 12/8/2025
Patent No. RE41,783, which does not expire until December 8, 2025.
Source
Add
Filing Date # Docket Text
9/8/2021Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 09/08/2021)
9/8/2021
  • Motion to Dismiss (Demurrer)
SO ORDERED, re 104 Stipulation of Dismissal filed by PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc., PF Prism IMB B.V., ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 9/8/21. (ntl) (Entered: 09/08/2021)
9/7/2021
  • Motion to Dismiss (Demurrer)by Π
STIPULATION of Dismissal by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF Prism IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 09/07/2021)
4/19/2021NOTICE OF SERVICE of Reply Expert Report of Dr. Joseph A. Fix, Ph.D. Regarding Obviousness, Enablement, and Written Description, Reply Expert Report of Dr. Richard Bergstrom, Ph.D. Regarding Obviousness, and Reply Expert Report of Dr. Simon Helfgott, M.D. Regarding Obviousness filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 04/19/2021)
1/19/2021NOTICE OF SERVICE of (1) Expert Report of Michael E. Weinblatt, M.D.; (2) Responsive Expert Report of Lawrence L. Fleckenstein, Pharm.D., Regarding Validity of U.S. Patent No. 9,937,181; and (3) Responsive Expert Report of Leah E. Appel, Ph.D., Regarding Validity of U.S. Patent No. 9,937,181 filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 01/19/2021)
11/9/2020SO ORDERED, re 100 Joint MOTION to Amend the Case Schedule and Set a New Trial Date -- Proposed Pretrial Order due by 12/10/2021. A Final Pretrial Conference is set for 12/20/2021 at 03:00 PM in Courtroom 6B. A 5-day Bench Trial is set for 1/3/2022 at 08:30 AM in Courtroom 6B. Signed by Judge Leonard P. Stark on 11/9/20. (ntl) (ntl). (Entered: 11/09/2020)
11/5/2020Joint MOTION to Amend the Case Schedule and Set a New Trial Date - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 11/05/2020)
10/22/2020REDACTED VERSION of 96 Letter by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Attachments: # 1 Exhibit A-L)(Dellinger, Megan) (Entered: 10/22/2020)
10/22/2020REDACTED VERSION of 95 Letter, by Teva Pharmaceuticals USA, Inc.. (Brauerman, Stephen) (Entered: 10/22/2020)
10/19/202097
  • Motion to CompelGranted
ORAL ORDER: Having reviewed the materials submitted in connection with the parties' discovery dispute (D.I. 95, 96), IT IS HEREBY ORDERED that Teva's request to compel Pfizer to produce certain information (a pricing survey and rebate spreadsheet) is GRANTED. The Court agrees with Teva that the requested information is relevant to Pfizer's contention that commercial success is a secondary consideration of nonobviousness of the patent-in-suit. (See D.I. 95 at 1) ("Both documents are highly relevant to the question of whether the alleged commercial success of Xeljanz XR is attributable to the patented feature of the product or, instead, to other factors, such as Pfizer's pricing strategy and rebates.") Teva's narrow request for these two documents was timely, as it closely followed revelation of their existence at a recent deposition, and there is good cause to permit this limited post-deadline discovery. Pfizer has failed to persuade the Court of the merits of its objections, including cumulativeness. IT IS FURTHER ORDERED that the teleconference scheduled for tomorrow is CANCELLED. ORDERED by Judge Leonard P. Stark on 10/19/20. (ntl) (Entered: 10/19/2020)
10/15/2020[SEALED] Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Responsive Discovery Dispute Letter. (Attachments: # 1 Exhibit A-L)(Dellinger, Megan) (Entered: 10/15/2020)
10/13/2020[SEALED] Letter to The Honorable Leonard P. Stark from Stephen B. Brauerman regarding Motion to Compel. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Certificate of Service)(Brauerman, Stephen) (Entered: 10/13/2020)
10/9/2020NOTICE OF SERVICE of Opening Expert Report of Dr. Richard Bergstrom, Ph.D. Regarding Obviousness filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 10/09/2020)
10/9/2020NOTICE OF SERVICE of Opening Expert Report of Dr. Joseph A. Fix, Ph.D. Regarding Obviousness, Enablement, and Written Description and Opening Expert Report of Dr. Simon Helfgott, M.D. Regarding Obviousness filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 10/09/2020)
10/9/2020NOTICE OF SERVICE of Opening Infringement Expert Report of Lawrence L. Fleckenstein, Pharm.D. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 10/09/2020)
10/7/202091
  • Order
ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for October 20, 2020 at 11:30 a.m. The parties can access the teleconference by dialing 877-336-1829 and using the access code 1408971. IT IS FURTHER ORDERED that not later than October 13, 2020, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than October 15, 2020, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 10/7/2020. (ntl) (Entered: 10/07/2020)
10/1/2020CORRECTING ENTRY: Corrected letter added to D.I. 90 per request of counsel. (ntl) (Entered: 10/01/2020)
10/1/2020[SEALED] Letter to The Honorable Leonard P. Stark from Stephen B. Brauerman regarding Discovery Dispute. (Attachments: # 1 Certificate of Service)(Brauerman, Stephen) (Main Document 90 replaced on 10/1/2020) (ntl). (Entered: 10/01/2020)
9/11/2020NOTICE OF SERVICE of Teva's Supplemental Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 09/11/2020)
9/11/2020NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendant's Interrogatory Nos. 4 and 5 filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 09/11/2020)
9/8/2020 STIPULATION Regarding the Deposition and Trial Testimony of Manisha Lamba by Teva Pharmaceuticals USA, Inc.. (Brauerman, Stephen) (Entered: 09/08/2020)
8/20/2020NOTICE to Take Deposition of Thomas C. Stock on September 3, 2020 at 9:30 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/20/2020)
8/20/2020NOTICE to Take Deposition of Jeff Lotz on August 25, 2020 at 9:30 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/20/2020)
8/20/2020NOTICE to Take Deposition of Joe Hoban on September 11, 2020, at 9:30 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/20/2020)
8/7/2020 STIPULATION regarding the Deposition and Trial Testimony of Scott Max Herbig by Teva Pharmaceuticals USA, Inc.. (Brauerman, Stephen) (Entered: 08/07/2020)
7/23/2020
  • Order
SO ORDERED, re 73 Proposed Amended Scheduling Order -- Proposed Pretrial Order due by 5/24/2021. A 5-day Bench Trial is set for 6/14/2021 at 08:30 AM in Courtroom 6B. A Final Pretrial Conference is set for 6/4/2021 at 11:00 AM in Courtroom 6B. Signed by Judge Leonard P. Stark on 7/23/20. (ntl) (Entered: 07/23/2020)
7/13/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 75 MOTION for Pro Hac Vice Appearance of Attorney Michael Bruns filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 7/13/20. (ntl) (Entered: 07/13/2020)
7/10/2020NOTICE to Take Deposition of Thomas C. Stock on August 27, 2020 filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/10/2020)
7/10/2020NOTICE to Take Deposition of Sriram Krishnaswami on July 14, 2020 filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/10/2020)
7/10/2020NOTICE to Take Deposition of Joe Hoban on August 14, 2020 filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/10/2020)
7/10/2020NOTICE to Take Deposition of Joseph Kushner, IV on August 6, 2020 filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/10/2020)
7/10/2020NOTICE to Take Deposition of Scott Max Herbig on August 11, 2020 filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/10/2020)
7/10/2020NOTICE to Take Deposition of Andrew Blanchard on August 4, 2020 filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/10/2020)
7/10/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Michael Bruns - filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certificate of Compliance)(Brauerman, Stephen) (Entered: 07/10/2020)
7/9/2020 STIPULATION Regarding The Deposition and Trial Testimony of Vincent DeMatteo by Teva Pharmaceuticals USA, Inc.. (Brauerman, Stephen) (Entered: 07/09/2020)
6/24/2020
  • Motionby Π
PROPOSED ORDER -- Amended Scheduling Order -- re 21 Scheduling Order,, by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 06/24/2020)
6/16/202072
  • Order
ORAL ORDER: Having reviewed the parties' joint status report (D.I. 71), IT IS HEREBY ORDERED that: (I) the parties' proposals on depositions and the timing to propose a new schedule are ADOPTED, and (II) the pretrial conference and trial are CONTINUED to dates to be determined. ORDERED by Judge Leonard P. Stark on 6/16/20. (ntl) (Entered: 06/16/2020)
6/15/2020Joint STATUS REPORT by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 06/15/2020)
4/23/2020
  • Motion to Stay
SO ORDERED, re 68 Stipulation and Order to Stay the Case -- Case Stayed. The April 24 teleconference is cancelled. Signed by Judge Leonard P. Stark on 4/23/20. (ntl) (Entered: 04/23/2020)
4/20/2020Joint STATUS REPORT by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 04/20/2020)
4/20/2020
  • Motion to Stayby Π
STIPULATION and [Proposed] Order to Stay the Case by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 04/20/2020)
4/20/202067
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that a status teleconference has been scheduled for April 24, 2020 at 11:45 a.m. Counsel for Pfizer shall initiate the teleconference and shall provide Chambers with the call-in information. Counsel shall submit a joint status report by April 23, 2020. ORDERED by Judge Leonard P. Stark on 4/20/20. (ntl) (Entered: 04/20/2020)
4/6/2020NOTICE OF SERVICE of Plaintiffs' Second Amended Infringement Claim Charts Regarding the Accused Product of Defendant Teva Pharmaceuticals USA, Inc. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 04/06/2020)
3/17/2020NOTICE OF SERVICE of Third Party Subpoenas filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brauerman, Stephen) (Entered: 03/17/2020)
3/17/2020 Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding request for teleconference to discuss revised schedule. (Dellinger, Megan) (Entered: 03/17/2020)
3/13/2020
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 63 MOTION for Pro Hac Vice Appearance of Attorney Michael E. Joffre filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 3/13/20. (ntl) (Entered: 03/13/2020)
3/13/2020
  • Motion to Extend Time
SO ORDERED, re 62 STIPULATION TO EXTEND TIME of Certain Fact Discovery Deadlines to Various Dates filed by PF PRISM IMB B.V., PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc. Signed by Judge Leonard P. Stark on 3/12/20. (ntl) (Entered: 03/13/2020)
3/10/2020
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Michael E. Joffre - filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of Michael E. Joffre)(Brauerman, Stephen) (Entered: 03/10/2020)
3/10/2020
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME of Certain Fact Discovery Deadlines to Various Dates - filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 03/10/2020)
3/10/2020
  • Order
SO ORDERED, re 60 Joint STIPULATION and [Proposed] Order Regarding Evidentiary Issues filed by PF PRISM IMB B.V., PF PRISM C.V., C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, Pfizer Inc. Signed by Judge Leonard P. Stark on 3/10/20. (ntl) (Entered: 03/10/2020)
3/9/2020NOTICE OF SERVICE of Plaintiff's Supplemental Responses and Objections to Defendant's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 03/09/2020)
3/4/2020
  • Motionby Π
Joint STIPULATION and [Proposed] Order Regarding Evidentiary Issues by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 03/04/2020)
2/25/2020NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 02/25/2020)
2/21/2020
  • Order
SO ORDERED, re 51 STIPULATION and Proposed Order Regarding Infringement of Claim 1 of U.S. Patent No. 9,937,181. Signed by Judge Leonard P. Stark on 2/21/20. (ntl) (Entered: 02/21/2020)
2/20/2020NOTICE to Take Deposition of Andrew Blanchard on March 11, 2020 at 9:00 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/20/2020)
2/20/2020NOTICE to Take Deposition of Vincent DeMatteo on March 13, 2020 at 9:00 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/20/2020)
2/20/2020NOTICE to Take Deposition of Thomas C. Stock on March 9, 2020 at 9:00 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/20/2020)
2/20/2020NOTICE to Take Deposition of Sriram Krishnaswami on March 4, 2020 at 9:00 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/20/2020)
2/20/2020NOTICE to Take Deposition of Joseph Kushner, IV on March 6, 2020 at 9:00 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/20/2020)
2/20/2020NOTICE to Take Deposition of Gregory Scott Goeken on March 2, 2020 at 9:00 a.m. filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/20/2020)
2/14/2020NOTICE OF SERVICE of Plaintiffs' Amended Infringement Claim Charts Regarding the Accused Product of Defendant Teva Pharmaceuticals USA, Inc. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 02/14/2020)
2/14/2020 STIPULATION and Proposed Order Regarding Infringement of Claim 1 of U.S. Patent No. 9,937,181 by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) (Entered: 02/14/2020)
2/10/2020NOTICE to Take Deposition of Plaintiffs Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V., PBG Puerto Rico LLC, and PF Prism IMB B.V. on a date and time mutually agreeable to the parties filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/10/2020)
2/10/2020NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on March 9, 2020 filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc..(Dellinger, Megan) (Entered: 02/10/2020)
1/27/2020
  • Motion to Extend Time
SO ORDERED, re 48 Joint STIPULATION TO EXTEND TIME to extend certain fact and expert discovery deadlines to various dates filed by Pfizer Inc. Signed by Judge Leonard P. Stark on 1/27/20. (ntl) (Entered: 01/27/2020)
1/21/2020
  • Motion to Extend Timeby Π
Joint STIPULATION TO EXTEND TIME to extend certain fact and expert discovery deadlines to various dates - filed by Pfizer Inc.. (Dellinger, Megan) (Entered: 01/21/2020)
1/15/2020
  • Order
SO ORDERED, re 46 MOTION to Add Plaintiffs and Amend the Case Caption (Unopposed) filed by Pfizer Inc. Signed by Judge Leonard P. Stark on 1/14/20. (ntl) (Entered: 01/15/2020)
1/10/2020Interim STATUS REPORT by Pfizer Inc.. (Dellinger, Megan) (Entered: 01/10/2020)
1/10/2020
  • Motionby Π
MOTION to Add Plaintiffs and Amend the Case Caption (Unopposed) - filed by Pfizer Inc.. (Dellinger, Megan) (Entered: 01/10/2020)
11/19/2019NOTICE requesting Clerk to remove Andrew Bledsoe as co-counsel. Reason for request: No longer with Arnold & Porter Kaye Scholer LLP. (Dellinger, Megan) (Entered: 11/19/2019)
11/19/2019NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's Second Set of Interrogatories filed by Pfizer Inc..(Dellinger, Megan) (Entered: 11/19/2019)
11/19/2019 NOTICE of Change of Firm Affiliation for Soumitra (Sam) Deka by Pfizer Inc. (Dellinger, Megan) (Entered: 11/19/2019)
10/11/2019NOTICE OF SERVICE of Teva's Second Set of Interrogatories to Plaintiff Pfizer Inc. (Nos. 5 and 6) filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 10/11/2019)
10/7/201941
  • Order
ORAL ORDER: Having reviewed the Letter to Judge Stark regarding Request to Cancel the Markman Hearing (D.I. 40), IT IS HEREBY ORDERED that the Markman hearing set for 11/26/2019 at 12:00 PM is cancelled. IT IS FURTHER ORDERED that the parties need not submit technology tutorials. Ordered by Judge Leonard P. Stark on 10/7/2019. (etg) (Entered: 10/07/2019)
10/2/2019 Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Request to Cancel the Markman Hearing Scheduled for November 26, 2019 - re 39 Claim Construction Chart. (Dellinger, Megan) (Entered: 10/02/2019)
10/2/2019
  • Motion for Claim Constructionby Π
CLAIM Construction Chart by Pfizer Inc.. (Dellinger, Megan) (Entered: 10/02/2019)
9/10/2019NOTICE OF SERVICE of Plaintiff's Claim Construction Opening Brief filed by Pfizer Inc..(Dellinger, Megan) (Entered: 09/10/2019)
9/6/2019
  • Motion for Claim Constructionby Π
CLAIM Construction Chart by Pfizer Inc.. (Attachments: # 1 Exhibit A-B)(Dellinger, Megan) (Entered: 09/06/2019)
8/27/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 35 MOTION for Pro Hac Vice Appearance of Attorney Andrew Bledsoe filed by Pfizer Inc. Signed by Judge Leonard P. Stark on 8/27/19. (ntl) (Entered: 08/27/2019)
8/26/2019NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.'s Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/26/2019)
8/26/2019
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Andrew Bledsoe - filed by Pfizer Inc.. (Dellinger, Megan) (Entered: 08/26/2019)
8/23/2019NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's First Set of Interrogatories filed by Pfizer Inc..(Dellinger, Megan) (Entered: 08/23/2019)
8/23/2019NOTICE OF SERVICE of Teva's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/23/2019)
8/22/2019NOTICE OF SERVICE of (1) Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Pfizer Inc.'s First Set of Interrogatories (Nos. 1-5), (2) Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Pfizer Inc.'s First Set of Requests (Nos. 1-26) for the Production of Documents and Things and (3) this Notice of Service filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/22/2019)
8/20/2019NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's First Set of Requests for Production filed by Pfizer Inc..(Dellinger, Megan) (Entered: 08/20/2019)
8/16/2019NOTICE OF SERVICE of Teva's Identification of Proposed Constructions for Identifed Terms filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/16/2019)
8/16/2019NOTICE OF SERVICE of Pfizer's Identification of Claim Terms Needing Construction and Proposed Constructions of Those Terms filed by Pfizer Inc..(Dellinger, Megan) (Entered: 08/16/2019)
8/9/2019NOTICE OF SERVICE of Plaintiff's Identification of Claim Terms Needing Construction filed by Pfizer Inc..(Dellinger, Megan) (Entered: 08/09/2019)
8/6/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 25 MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Stephanie Piper, Michael Sapiro and Soumitra Deka filed by Pfizer Inc. Signed by Judge Leonard P. Stark on 8/6/19. (ntl) (Entered: 08/06/2019)
8/5/2019NOTICE OF SERVICE of (1) Plaintiff's Fed. R. Civ. P. 26(a) Disclosure Statement and (2) Plaintiff's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Pfizer Inc..(Dellinger, Megan) (Entered: 08/05/2019)
8/5/2019NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s Rule 26(a)(1) Initial Disclosures filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/05/2019)
8/5/2019
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Stephanie Piper, Michael Sapiro and Soumitra Deka - filed by Pfizer Inc.. (Dellinger, Megan) (Entered: 08/05/2019)
8/1/2019NOTICE OF SERVICE of Teva's First Set of Interrogatories to Plaintiff Pfizer Inc. (Nos. 1-4) filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 08/01/2019)
7/30/201923
  • Order
ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 7/30/2019. (dlb) (Entered: 07/30/2019)
7/30/2019CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) (Entered: 07/30/2019)
7/29/2019NOTICE OF SERVICE of Plaintiff's Infringement Claim Charts Regarding the Accused Product of Defendant Teva Pharmaceuticals USA, Inc. filed by Pfizer Inc..(Dellinger, Megan) (Entered: 07/29/2019)
7/24/2019
  • Scheduling Order
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 2/21/2020. Status Report due by 1/10/2020. A Markman Hearing is set for 11/26/2019 at 12:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 9/28/2020. A Final Pretrial Conference is set for 10/9/2020 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Bench Trial is set for 10/19/2020 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 7/24/19. (ntl) (Entered: 07/24/2019)
7/23/2019NOTICE OF SERVICE of (1) Pfizer Inc.'s First Set of Interrogatories (Nos. 1-5) to Teva Pharmaceuticals USA, Inc. and (2) Pfizer Inc.'s First Set of Requests (Nos. 1-26) to Teva Pharmaceuticals USA, Inc. for the Production of Documents and Things filed by Pfizer Inc..(Dellinger, Megan) (Entered: 07/23/2019)
7/23/201919
  • Order
ORAL ORDER: Having reviewed the proposed scheduling order (D.I. 18), IT IS HEREBY ORDERED that the teleconference scheduled for tomorrow is CANCELLED. ORDERED by Judge Leonard P. Stark on 7/23/19. (ntl) (Entered: 07/23/2019)
7/22/2019 Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Proposed Scheduling Order - re 16 Order Setting Teleconference,,. (Attachments: # 1 Proposed Scheduling Order)(Dellinger, Megan) (Entered: 07/22/2019)
7/22/2019NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Requests for Production to Pfizer Inc. (Nos. 1-55) filed by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 07/22/2019)
7/17/201916
  • Order
ORAL ORDER: The Court having reviewed but not entered the parties' proposed scheduling order, and that proposal having contained disputes as well as dates that have now passed, IT IS HEREBY ORDERED that: (i) no later than July 22, the parties shall file a revised proposed scheduling order; and (ii) the Court will hold a scheduling teleconference on July 24 beginning at 11:30 a.m. Plaintiff's counsel shall initiate the call to (302) 573-4571. ORDERED by Judge Leonard P. Stark on 7/17/19. (ntl) (Entered: 07/17/2019)
7/15/2019
  • Order
SO ORDERED, re 15 Stipulated Protective Order. Signed by Judge Leonard P. Stark on 7/15/19. (ntl) (Entered: 07/15/2019)
7/11/2019
  • Motionby Π
PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Pfizer Inc.. (Dellinger, Megan) (Entered: 07/11/2019)
6/24/2019
  • Motion to Extend Time
SO ORDERED, re 14 Joint STIPULATION TO EXTEND TIME Plaintiff's Initial Infringement Contentions and Defendant's Initial Invalidity Contentions to July 29, 2019 and August 26, 2019 filed by Pfizer Inc. Signed by Judge Leonard P. Stark on 6/24/19. (ntl) (Entered: 06/24/2019)
6/21/2019
  • Motion to Extend Timeby Π
Joint STIPULATION TO EXTEND TIME Plaintiff's Initial Infringement Contentions and Defendant's Initial Invalidity Contentions to July 29, 2019 and August 26, 2019 - filed by Pfizer Inc.. (Dellinger, Megan) (Entered: 06/21/2019)
5/10/2019NOTICE OF SERVICE of Plaintiff's Identification of Accused Product and Asserted Patent filed by Pfizer Inc..(Dellinger, Megan) (Entered: 05/10/2019)
4/26/2019 Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Proposed Scheduling Order - re 11 Order,. (Attachments: # 1 Proposed Scheduling Order)(Dellinger, Megan) (Entered: 04/26/2019)
4/12/201911
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than April 26, 2019. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 4/12/19. (ntl) (Entered: 04/12/2019)
2/26/2019
  • Answerby Π
ANSWER to 8 Answer to Complaint, Counterclaim by Pfizer Inc..(Dellinger, Megan) (Entered: 02/26/2019)
2/5/2019 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Brauerman, Stephen) (Entered: 02/05/2019)
2/5/2019
  • Answerby Δ
ANSWER to 1 Complaint, Defenses, and, COUNTERCLAIM against Pfizer Inc. by Teva Pharmaceuticals USA, Inc..(Brauerman, Stephen) (Entered: 02/05/2019)
1/31/2019Pro Hac Vice Attorney J.C. Rozendaal, Chandrika Vira, and Lauren Watt for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) (Entered: 01/31/2019)
1/30/2019
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 7 MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Chandrika Vira, and Lauren Watt filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 1/30/19. (ntl) (Entered: 01/30/2019)
1/29/2019
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Chandrika Vira, and Lauren Watt - filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Certification of J.C. Rozendaal, # 2 Certification of Chandrika Vira, # 3 Certification of Lauren Watt)(Brauerman, Stephen) (Entered: 01/29/2019)
12/12/2018Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) (Entered: 12/12/2018)
12/10/2018WAIVER OF SERVICE returned executed by Pfizer Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 12/7/2018, answer due 2/5/2019. (Blumenfeld, Jack) (Entered: 12/10/2018)
12/7/2018Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 12/7/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) (Entered: 12/07/2018)
12/7/2018 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc. (ceg) (Entered: 12/07/2018)
12/7/2018Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,937,181 B2. (ceg) (Entered: 12/07/2018)
12/7/2018 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/31/2018. Date of Expiration of Patent: 3/14/2034. (ceg) (Entered: 12/07/2018)
12/7/2018Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) (Entered: 12/07/2018)
12/7/2018
  • Complaint
COMPLAINT FOR PATENT INFRIGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2519566.) - filed by Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ceg) (Entered: 12/07/2018)